Similar Items: Design, optimisation and validation of molecular diagnostic assays for BRAF p.Val600Glu and associated genetic factors within hairy cell leukemia (HCL) and HCL-like entities at Tygerberg Hospital, South Africa
- How can virtual implementation modelling inform the scale-up of new molecular diagnostic tools for tuberculosis?
- CXCL13, CXCL10 and CXCL8 as indicators of ocular and neurological involvement in patients with ocular syphilis: an observational descriptive study
- Design and validation of molecular diagnostic assays for key prognostic biomarkers, FLT3-ITD, NPM1, DNMT3A and CEBPA in cytogenetically normal aml patients at Tygerberg Hospital, South Africa
- Verification and correlation of JAK2 p.V617F diagnostic assays and haematologic implications of JAK2 p.Val617Phe allele burden in Myeloproliferative neoplasm patients at Tygerberg Hospital
- The epidemiology of rabies in selected sub-Saharan countries
- The histopathological diagnosis of myelodysplasticsyndromes and acute nonlymphoblastic leukaemia using glycol methacrylate embedded bone marrow biopsies
Author: Swanepoel, Carmen
- Design, optimisation and validation of molecular diagnostic assays for BRAF p.Val600Glu and associated genetic factors within hairy cell leukemia (HCL) and HCL-like entities at Tygerberg Hospital, South Africa
- Screening and characterisation of BCR::ABL1 kinase domain mutations in chronic myeloid leukaemia participants at Tygerberg Hospital, South Africa
- Verification and correlation of JAK2 p.V617F diagnostic assays and haematologic implications of JAK2 p.Val617Phe allele burden in Myeloproliferative neoplasm patients at Tygerberg Hospital
- Design and validation of molecular diagnostic assays for key prognostic biomarkers, FLT3-ITD, NPM1, DNMT3A and CEBPA in cytogenetically normal aml patients at Tygerberg Hospital, South Africa
- Imatinib resistance : the role of pharmacogenetic variability in a South African chronic myeloid leukemia cohort
- Evaluating the role of long-term urine bio-banking on the stability of urine bio-markers in the diagnosis of pre-eclampsia